These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19201037)

  • 1. Microglial activation is inhibited by corticosterone in dopaminergic neurodegeneration.
    Sugama S; Takenouchi T; Kitani H; Fujita M; Hashimoto M
    J Neuroimmunol; 2009 Mar; 208(1-2):104-14. PubMed ID: 19201037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Sugama S; Wirz SA; Barr AM; Conti B; Bartfai T; Shibasaki T
    Neuroscience; 2004; 128(2):451-8. PubMed ID: 15350655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M
    J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism.
    Zhao F; Cai T; Liu M; Zheng G; Luo W; Chen J
    Toxicol Sci; 2009 Jan; 107(1):156-64. PubMed ID: 18836210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model.
    Kang JM; Park HJ; Choi YG; Choe IH; Park JH; Kim YS; Lim S
    Brain Res; 2007 Feb; 1131(1):211-9. PubMed ID: 17173870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice.
    Liu J; Wang MW; Gu P; Ma QY; Wang YY; Geng Y; Yuan ZY; Cui DS; Zhang ZX; Ma L; Zhang BH; Zhou MG; Zhu AP
    Brain Res; 2010 Jul; 1345():213-20. PubMed ID: 20546706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by inhibiting microglial cell activation.
    Li R; Peng N; Du F; Li XP; Le WD
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):376-80. PubMed ID: 16624731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K; Miller DB; O'Callaghan JP
    J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
    Kim S; Moon M; Park S
    J Endocrinol; 2009 Sep; 202(3):431-9. PubMed ID: 19570816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys.
    Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Izal-Azcárate A; Belzunegui S; Marcilla I; López B; Luquin MR
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):977-84. PubMed ID: 19680145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys.
    Hurley SD; O'Banion MK; Song DD; Arana FS; Olschowka JA; Haber SN
    Exp Neurol; 2003 Dec; 184(2):659-68. PubMed ID: 14769357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
    Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice.
    Sugama S; Yang L; Cho BP; DeGiorgio LA; Lorenzl S; Albers DS; Beal MF; Volpe BT; Joh TH
    Brain Res; 2003 Feb; 964(2):288-94. PubMed ID: 12576189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.
    Tripanichkul W; Sripanichkulchai K; Finkelstein DI
    Brain Res; 2006 Apr; 1084(1):28-37. PubMed ID: 16564034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity.
    McLaughlin P; Zhou Y; Ma T; Liu J; Zhang W; Hong JS; Kovacs M; Zhang J
    Glia; 2006 Apr; 53(6):567-82. PubMed ID: 16419087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.
    Liberatore GT; Jackson-Lewis V; Vukosavic S; Mandir AS; Vila M; McAuliffe WG; Dawson VL; Dawson TM; Przedborski S
    Nat Med; 1999 Dec; 5(12):1403-9. PubMed ID: 10581083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of MPTP-induced dopaminergic neurodegeneration in the mouse substantia nigra by laser capture microdissection.
    Stephenson D; Ramirez A; Long J; Barrezueta N; Hajos-Korcsok E; Matherne C; Gallagher D; Ryan A; Ochoa R; Menniti F; Yan J
    J Neurosci Methods; 2007 Jan; 159(2):291-9. PubMed ID: 16949674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice.
    Hong Z; Wang G; Gu J; Pan J; Bai L; Zhang S; Chen SD
    Eur J Neurosci; 2007 Sep; 26(6):1500-8. PubMed ID: 17714494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.